This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

WIPO Genetic Resources treaty will face substantial pushback in US

By Melissa Ritti ( April 29, 2025, 12:01 GMT | Comment) -- A hearing at US Patent and Trademark Office headquarters today on heightened international disclosure requirements for inventions that make use of genetic resources or associated traditional knowledge could be little more than a formality. Stakeholders appear largely opposed to the measure, setting the stage for a rare US break with the World Intellectual Property Organization. While the disagreement is uncommon, it is at least topically consistent — the US remains a noteworthy holdout, joined only by the Holy See, to the 1993 Convention on Biological Diversity and its 2014 subsidiary Nagoya Protocol for regulating access to genetic resources.The US, as an original signatory to the Convention Establishing the World Intellectual Property Office, has more or less stayed in lockstep with the UN’s IP wing since its inception in 1968....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections